Dexamethasone Use in Brain Cancer Patients

Initial Dosing and Duration Considerations

• The American College of Oncology recommends dexamethasone for the shortest duration possible in brain cancer patients, with tapering initiated as soon as clinical symptoms are controlled, typically over 2-4 weeks for short-term use 1, 2
• Dexamethasone is the corticosteroid of choice for treating symptomatic tumor-associated brain edema due to its minimal mineralocorticoid effects 1, 3

Monitoring and Tapering

• Regular clinical examinations should be conducted to assess ongoing need for steroid therapy and to determine when tapering should be initiated 2, 5
• Patients requiring steroid treatment for >4 weeks should receive Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole 1, 6

Important Considerations

• Prolonged steroid use is associated with significant adverse effects, including increased risk of infections, metabolic complications, musculoskeletal effects, and psychiatric disturbances 1, 2
• Evidence suggests that steroid use may be associated with inferior survival in glioblastoma patients 2

Special Situations

• Prophylactic use of steroids is increasingly discouraged unless clinically indicated 2, 5

Common Pitfalls to Avoid

• Failure to provide PJP prophylaxis for patients on prolonged steroid therapy can lead to increased risk of infections 1, 6